APA (7th ed.) Citation

Alafeefy, A. M., Ashour, A. E. A., Prasad, O., Sinha, L., Pathak, S., Alasmari, F. A., . . . Abdel-Aziz, H. A. (2015). Development of certain novel N-(2-(2-(2-oxoindolin-3-ylidene)hydrazinecarbonyl)phenyl)-benzamides and 3-(2-oxoindolin-3-ylideneamino)-2-substituted quinazolin-4(3H)-ones as CFM-1 analogs: Design, synthesis, QSAR analysis and anticancer activity. Elsevier.

Chicago Style (17th ed.) Citation

Alafeefy, Ahmed M., Abdelkader Elbadawy Abbas Ashour, Onkar Prasad, Leena Sinha, Shilendra Pathak, Fatimah A. Alasmari, Arun K. Rishi, and Hatem A. Abdel-Aziz. Development of Certain Novel N-(2-(2-(2-oxoindolin-3-ylidene)hydrazinecarbonyl)phenyl)-benzamides and 3-(2-oxoindolin-3-ylideneamino)-2-substituted Quinazolin-4(3H)-ones as CFM-1 Analogs: Design, Synthesis, QSAR Analysis and Anticancer Activity. Elsevier, 2015.

MLA (8th ed.) Citation

Alafeefy, Ahmed M., et al. Development of Certain Novel N-(2-(2-(2-oxoindolin-3-ylidene)hydrazinecarbonyl)phenyl)-benzamides and 3-(2-oxoindolin-3-ylideneamino)-2-substituted Quinazolin-4(3H)-ones as CFM-1 Analogs: Design, Synthesis, QSAR Analysis and Anticancer Activity. Elsevier, 2015.